is created by a controlled thaw of frozen plasma that allows for precipitation of large molecules. It is then centrifuged with the final product containing fibrinogen, fibronectin, vWF, factor VIII, and factor XIII (1 unit of plasma typically generates 10–20 mL of cryoprecipitate) (Table 16-9: Indications for the use of Cryoprecipitate).

Hemostasis and Transfusion Medicine

1. Hemostasis and Coagulation
2. Fibrinolysis
3. Laboratory Evaluation of Hemostasis
4. Laboratory Evaluation of Primary Hemostasis
5. Laboratory Evaluation of Secondary Hemostasis and Coagulation
6. Diagnosis of Thromboembolic Disorders
7. Monitoring Anticoagulation Therapeutic Agents
8. Blood Component Production
9. Blood Products and Transfusion Thresholds
10. Physiologic Compensation for Anemia
11. Platelets
12. Fresh Frozen Plasma
13. Cryoprecipitate
14. The Risks of Blood Product Administration
15. Blood Conservation Strategies
16. Disorders of Hemostasis: Diagnosis and Treatment
17. Anticoagulation and Pharmacologic Therapy
18. Prothrombin Complex Concentrates
19. Desmopressin
20. Antifibrinolytic Therapy